DOI: 10.1007/s00259-017-3815-0Pages: 1-2

Single high dose versus repeated bone-targeted radionuclide therapy

1. GH Hospital Frankfurt (Oder), Department of Nuclear Medicine

Correspondence to:
K. Liepe
Tel: +49 335 548-2921
Email: knut.liepe@klinikumffo.de

Close

Abstract

To access the full text, please Sign in

If you have institutional access, please click here

  • Accepted: Aug 21, 2017
  • Online: Aug 31, 2017

Article Tools

eanm
EJNMMI Ad